Tramadol Hydrochloride
Product Images NDC 45865-969

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 45865-969). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (33a5de83 A974 48a5 8ba6 4c1b97515615 01)

Chemical structure of tramadol hydrochloride showing the molecular arrangement including methoxyphenyl and cyclohexanol groups attached to a dimethylaminopropyl side chain with hydrochloride indicated.*

FDA Label Image

Image-2 (33a5de83 A974 48a5 8ba6 4c1b97515615 02)

A line graph comparing tramadol concentration (ng/mL) over 24 hours with two formulations: Tramadol Hydrochloride Extended-Release Tablets (200 mg once daily) and Tramadol Hydrochloride Tablets (50 mg every 6 hours). The x-axis represents time in hours, and the y-axis indicates tramadol concentration in nanograms per milliliter.*

FDA Label Image

Image-3 (33a5de83 A974 48a5 8ba6 4c1b97515615 03)

A line graph comparing M1 metabolite concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg taken once daily versus Tramadol Hydrochloride Tablets 50 mg taken every six hours. The graph shows concentration changes over time with two distinct data sets represented by filled and open circles.*

FDA Label Image

Image-4 (33a5de83 A974 48a5 8ba6 4c1b97515615 04)

A line graph titled "Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis Patients Achieving Various Levels of Response Threshold." It depicts the percent of patients achieving response (y-axis) against response threshold as percent improvement from baseline (x-axis). The graph compares Tramadol Hydrochloride Extended-Release Tablets at 100 mg, 200 mg, 300 mg, and 400 mg doses versus placebo, using distinct markers for each group.*

FDA Label Image

Image-5 (33a5de83 A974 48a5 8ba6 4c1b97515615 05)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis Patients Achieving Various Levels of Response Threshold.' It displays the percent of patients achieving response on the vertical axis and response threshold as percent improvement from baseline on the horizontal axis. Two lines represent Tramadol Hydrochloride Extended-Release Tablets and Placebo, with the tramadol line consistently higher across response thresholds.*

FDA Label Image

Pdp (969)

The image shows a white and green prescription label for TRAMADOL HCL ER tablets 100 mg by Medsource Pharmaceuticals. The label indicates it is a generic for Ultram ER, with a quantity of 30 tablets. It instructs to take one tablet every set number of hours as needed for pain and advises not to crush, chew, or drink alcohol. The label includes lot and expiration date fields, the manufacturer Lupin Limited, and a federal law warning about drug transfer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.